Opicapone and acute levodopa challenge test: the big issue

被引：0
|
作者：
Francesco Cavallieri
Valentina Fioravanti
Franco Valzania
机构：
[1] Neurology Unit,Neuromotor and Rehabilitation Department
[2] Azienda USL-IRCCS Di Reggio Emilia,Clinical and Experimental Medicine PhD Program
[3] University of Modena and Reggio Emilia,undefined
来源：
Acta Neurologica Belgica | 2021年 / 121卷
关键词：
Deep brain stimulation; Parkinson’s disease; Opicapone; Washout;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1347 / 1349
页数：2
相关论文
共 50 条
  • [41] Study-Design to Assess the Effect of Opicapone on Levodopa PK at Different Levodopa-Optimized Treatment Regimens
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Moreira, J.
    Rocha, J.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 718 - 718
  • [42] Levodopa acute challenge test in a group of patients with diffuse Lewy body disease compared with a group of patients with Parkinson's disease
    Del Dotto, P.
    Giambaccini, G.
    Ceravolo, R.
    Lucetti, C.
    Logi, C.
    Berti, C.
    Bemardini, S.
    Rossi, C.
    Bonuccelli, U.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 317 - 318
  • [43] Different patterns of acute saccadic responses to levodopa challenge test in de novo parkinson's disease: possibile prognostic implications
    Terravecchia, C.
    Mostile, G.
    Chisari, C. G.
    Luca, A.
    Terranova, R.
    Donzuso, G.
    Cicero, C. E.
    Sciacca, G.
    Nicoletti, A.
    Zappia, M.
    MOVEMENT DISORDERS, 2022, 37 : S467 - S467
  • [44] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C. W.
    Kieburtz, K. D.
    Liang, G. S.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    MOVEMENT DISORDERS, 2019, 34 : S7 - S7
  • [45] Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide
    Schade, Sebastian
    Mollenhauer, Brit
    Trenkwalder, Claudia
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (03): : 343 - 345
  • [46] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C.
    Kieburtz, K.
    Liang, G.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    MOVEMENT DISORDERS, 2019, 34 : S62 - S62
  • [47] The Parkinson's Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge
    Pinter, David
    Martinez-Martin, Pablo
    Janszky, Jozsef
    Kovacs, Norbert
    PARKINSONS DISEASE, 2019, 2019
  • [48] Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses
    Ye, Lan
    Sani, Sam Sadeghi
    Sanches, Linda Veith
    Krey, Lea Farina Magdalena
    Wegner, Florian
    Hoellerhage, Matthias
    Schrader, Christoph
    Hoeglinger, Gunter
    Klietz, Martin
    BRAIN SCIENCES, 2024, 14 (10)
  • [49] Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test
    Fabbri, Margherita
    Coelho, Miguel
    Guedes, Leonor Correia
    Chendo, Ines
    Sousa, Catarina
    Rosa, Mario M.
    Abreu, Daisy
    Costa, Nilza
    Godinho, Catarina
    Antonini, Angelo
    Ferreira, Joaquim J.
    PARKINSONISM & RELATED DISORDERS, 2017, 39 : 37 - 43
  • [50] Frailty phenotype and the role of levodopa challenge test in geriatric inpatients with mild parkinsonian signs
    Seiffert, Piotr
    Derejczyk, Jarosaw
    Kawa, Jacek
    Marcisz, Czeslaw
    Czernek, Malgorzata
    Szymszal, Jan
    Kapko, Wojciech
    Bugdol, Monika
    Torbus, Anna
    Stepien-Wyrobiec, Olga
    BIOGERONTOLOGY, 2017, 18 (04) : 641 - 650
12345